TELOMERASE-PEPTIDE VACCINE TOGETHER WITH GEMCITABINE IN ADVANCED PANCREATIC CANCER PATIENTS

被引：0
|
作者：
Staff, C. E. B. [1 ]
Mozaffari, F. M. [1 ]
Liljefors, M. [1 ]
Mosolits, S. [1 ]
Frodin, J. [1 ]
Choudhury, A. [1 ]
Mellstedt, H. [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [31] Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer
    Emmanuel Mitry
    Pascal Hammel
    Gaël Deplanque
    Françoise Mornex
    Philippe Levy
    Jean-François Seitz
    Alain Moussy
    Jean-Pierre Kinet
    Olivier Hermine
    Philippe Rougier
    Eric Raymond
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 395 - 403
  • [32] GEMCITABINE PLUS RADIOTHERAPY IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED PANCREATIC CANCER
    Otsuka, T.
    Kamachi, S.
    Akiyama, T.
    Fujimoto, M.
    Kawazoe, S.
    Ureshino, N.
    Watanabe, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 161 - 161
  • [33] Combination chemotherapy with gemcitabine and cisplatin in patients (pts) with advanced pancreatic cancer
    Agbarya, Abed
    Ben-Shachar, Menachem
    Nasrallah, Suheil
    Faraggi, David
    Vered, Shiraz
    Epelbaum, Ron
    ANNALS OF ONCOLOGY, 2006, 17 : 321 - 321
  • [34] Prognostic factors in gemcitabine refractory advanced pancreatic cancer patients.
    Nakachi, K
    Furuse, J
    Ishii, H
    Yoshino, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 368S - 368S
  • [35] Gemcitabine cisplatin regimen in patients with advanced or metastatic pancreatic cancer (AMPC)
    Boudjella, Abdelkader El Hakim
    Fethia, Braneci
    Nacera, Caid
    Radia, Benemla
    Louiza, Saoudi
    Soumia, Rekkache
    Radia, Ramoul
    Farida, Smaili
    ANNALS OF ONCOLOGY, 2017, 28
  • [36] Clinical response benefit in patients with advanced pancreatic cancer - Role of gemcitabine
    Carmichael, J
    DIGESTION, 1997, 58 (06) : 503 - 507
  • [37] Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer.
    de Lange, SM
    van Groeningen, CJ
    Giaccone, G
    Pinedo, HM
    Meijer, OWM
    Langendijk, JA
    Slotman, BJ
    CLINICAL CANCER RESEARCH, 2000, 6 : 4540S - 4541S
  • [38] Phase II study of curcumin and gemcitabine in patients with advanced pancreatic cancer
    Epelbaum, R.
    Vizel, B.
    Bar-Sela, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer
    Marechal, Raphael
    Demols, Anne
    Gay, France
    de Maertelaer, Viviane
    Arvanitaki, Marianna
    Hendlisz, Alain
    Van Laethem, Jean-Luc
    PANCREAS, 2008, 36 (03) : E16 - E21
  • [40] A peptide-based neoantigen vaccine for patients with advanced pancreatic cancer refractory to standard treatment.
    Yang, Liu
    Chen, Shuqing
    Mo, Fan
    Chen, Zheling
    Jiang, Jiahong
    Zhang, Shanshan
    Han, Ning
    Xu, Yunyun
    Ma, Dongying
    Wang, Huimin
    Guo, Xiaojie
    Luo, Kai
    Qiu, Min
    Huang, Qinxue
    Liu, Liang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345